Literature DB >> 6406631

Apolipoproteins of high, low, and very low density lipoproteins in human bile.

R B Sewell, S J Mao, T Kawamoto, N F LaRusso.   

Abstract

We tested the hypothesis that apolipoproteins, the protein constituents of plasma lipoproteins, are secreted into bile. We examined human gallbladder bile obtained at surgery (N = 54) from subjects with (N = 44) and without (N = 10) gallstones and hepatic bile collected by T-tube drainage (N = 9) after cholecystectomy. Using specific radioimmunoassays for human apolipoproteins A-I and A-II, the major apoproteins of high density lipoproteins, for apolipoproteins C-II and C-III, major apoproteins of very low density lipoproteins, and for apolipoprotein B, the major apoprotein of low density lipoproteins, we found immunoreactivity for these five apolipoproteins in every bile sample studied in concentrations up to 10% of their plasma values. Using double immunodiffusion, we observed complete lines of identity between bile samples and purified apolipoproteins A-I, A-II, or C-II. Using molecular sieve chromatography, we found identical elution profiles for biliary apolipoproteins A-I, A-II and B and these same apolipoproteins purified from human plasma. When we added high density lipoproteins purified from human plasma to lipoprotein-free solutions perfusing isolated rat livers, we detected apolipoproteins A-I and A-II in bile. Similarly, when we added low density lipoproteins purified from human plasma to lipoprotein-free solutions perfusing isolated livers of rats treated with ethinyl estradiol in order to enhance hepatic uptake of low-density lipoproteins, we found apolipoprotein B in bile. These data indicate that apolipoproteins can be transported across the hepatocyte and secreted into bile.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406631

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  16 in total

Review 1.  Defective acid base regulation by the gall bladder epithelium and its significance for gall stone formation.

Authors:  J N Plevris; I A Bouchier
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

2.  Biliary copper excretion by hepatocyte lysosomes in the rat. Major excretory pathway in experimental copper overload.

Authors:  J B Gross; B M Myers; L J Kost; S M Kuntz; N F LaRusso
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

3.  Fish oil, enriched with polyunsaturated fatty acids of the omega-3-type accelerates the nucleation time in healthy subjects.

Authors:  P Janowitz; W Swobodnik; J G Wechsler; A Janowitz; D Saal; H Ditschuneit
Journal:  Klin Wochenschr       Date:  1991-05-03

4.  Partial replacement of bile salts causes marked changes of cholesterol crystallization in supersaturated model bile systems.

Authors:  T Nishioka; S Tazuma; G Yamashita; G Kajiyama
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

5.  Reverse cholesterol transport is elevated in carboxyl ester lipase-knockout mice.

Authors:  Lisa M Camarota; Laura A Woollett; Philip N Howles
Journal:  FASEB J       Date:  2011-01-06       Impact factor: 5.191

6.  Stabilization of biliary lipid particles by ursodeoxycholic acid. Prolonged nucleation time in human gallbladder bile.

Authors:  S Mizuno; S Tazuma; G Kajiyama
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

7.  Measurement of apolipoprotein A1 in cholesterol gallstones and gallbladder bile of patients with gallstones.

Authors:  T Hasegawa; I Makino
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

8.  Biliary excretion of iron from hepatocyte lysosomes in the rat. A major excretory pathway in experimental iron overload.

Authors:  G D LeSage; L J Kost; S S Barham; N F LaRusso
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

9.  Dietary fat and fatty acids modulate cholesterol cholelithiasis in the hamster.

Authors:  B I Cohen; E H Mosbach; N Ayyad; S Miki; C K McSherry
Journal:  Lipids       Date:  1992-07       Impact factor: 1.880

10.  Mechanism of action of gemfibrozil on lipoprotein metabolism.

Authors:  K Saku; P S Gartside; B A Hynd; M L Kashyap
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.